Baylor College Researchers Identify Purine Synthesis as Biological Shield Against Artery Disease Progression

Baylor College researchers discover that blood vessels use purine synthesis to repair DNA and slow atherosclerosis, raising alerts for certain cancer drugs.

By: AXL Media

Published: Apr 28, 2026, 10:45 AM EDT

Source: Information for this report was sourced from Baylor College of Medicine

A Dynamic Defense Against Vascular Stress

The traditional understanding of atherosclerosis has long focused on the passive accumulation of fatty deposits, but new research suggests that the cells lining our arteries are active combatants against vascular injury. A team led by Dr. Yuqing Huo at Baylor College of Medicine has identified a specific metabolic "switch" that allows endothelial cells to protect themselves from the genomic stress caused by disturbed blood flow. This discovery provides a critical missing link in cardiovascular medicine, explaining why some individuals develop arterial hardening despite maintaining low cholesterol levels. By focusing on the non-fat drivers of vascular damage, researchers have opened a new frontier in the prevention of heart attacks and strokes.

The Role of Purine Synthesis in DNA Repair

At the center of this protective mechanism is the synthesis of purines, the essential building blocks of DNA. When blood vessels are exposed to disturbed flow, the resulting mechanical stress triggers DNA damage within the endothelial lining. To counteract this, the cells reprogram their metabolism to increase the production of purines, facilitating rapid genomic repair. The study utilized advanced mouse models to demonstrate that this metabolic shift is not a byproduct of disease but a targeted survival strategy. This cellular resilience is what maintains the integrity of the endothelial barrier, preventing the inflammatory infiltration that leads to advanced atherosclerotic lesions.

Disrupting the Shield Accelerates Disease

To validate the importance of this pathway, the researchers conducted experiments where they deleted Atic, a primary enzyme involved in the creation of new purines. The results were immediate and severe: the loss of this single enzyme led to widespread endothelial cell death and a rapid breakdown of the vascular barrier. Without the ability to repair DNA, the arteries in the test models developed accelerated atherosclerosis at a rate significantly higher than the control group. Conversely, when the team supplemented the models with purines, the damage was largely reversed, confirming that purine availability is a decisive factor in arterial health.